Cargando…

Introduction of the Rapid Deployment Aortic Valve System Use in Elderly Patients With Endocarditis

INTRODUCTION: The rapid-deployment valve system (RDVS) was introduced to facility minimally invasive aortic valve replacement. In this study we evaluate the potential benefits of RDVS in elderly high-risk patients with endocarditis of the aortic valve. MATERIALS AND METHODS: Since the introduction o...

Descripción completa

Detalles Bibliográficos
Autores principales: Öner, Alper, Hemmer, Christoph, Alozie, Anthony, Löser, Benjamin, Dohmen, Pascal M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8980357/
https://www.ncbi.nlm.nih.gov/pubmed/35391848
http://dx.doi.org/10.3389/fcvm.2022.774189
_version_ 1784681373396631552
author Öner, Alper
Hemmer, Christoph
Alozie, Anthony
Löser, Benjamin
Dohmen, Pascal M.
author_facet Öner, Alper
Hemmer, Christoph
Alozie, Anthony
Löser, Benjamin
Dohmen, Pascal M.
author_sort Öner, Alper
collection PubMed
description INTRODUCTION: The rapid-deployment valve system (RDVS) was introduced to facility minimally invasive aortic valve replacement. In this study we evaluate the potential benefits of RDVS in elderly high-risk patients with endocarditis of the aortic valve. MATERIALS AND METHODS: Since the introduction of RDVS in our institution in December 2017 through October 2021, EDWARDS INTUITY rapid-deployment prosthesis (Model 8300A, Edwards Lifesciences, Irvine, CA, USA) has been implanted in a total of 115 patients for different indications by a single surgeon. Out of one-hundred and fifteen cases of RDVS implantation, seven patients with a median age of 77 yrs. (range 62–84yrs.), suffered from active infective endocarditis of the aortic valve. The median EuroSCORE II of these highly selected patient cohort was 77% (range 19–80%). Patient data were evaluated perioperatively including intra-operative data as well as in-hospital morbidity/mortality and follow-up after discharge from hospital. RESULTS: Three patients underwent previous cardiac surgery. Concomitant procedures were performed in six patients including, ascending aorta replacement (n = 3), mitral valve repair (n = 1), pulmonary valve replacement (n = 1), bypass surgery (n = 1), left atrial appendix resection (n = 1) and anterior mitral valve repair (n = 1). Median aortic cross-clamp and cardiopulmonary bypass time was 56 min (range 29–122 min) and 81 min (range 45–162 min.), respectively. Post-operative complications in these elderly high-risk patients were atrial fibrillation (n = 3) and re-exploration for pericardial effusion (n = 1). One pacemaker implantation was required on postoperative day 6 due to sick sinus syndrome. There was one in-hospital death (14%) and one during follow-up (14%). CONCLUSION: Rapid-deployment aortic valve system seems to be a viable option with acceptable morbidity and mortality in elderly high-risk patients with active infective endocarditis of the aortic valve.
format Online
Article
Text
id pubmed-8980357
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-89803572022-04-06 Introduction of the Rapid Deployment Aortic Valve System Use in Elderly Patients With Endocarditis Öner, Alper Hemmer, Christoph Alozie, Anthony Löser, Benjamin Dohmen, Pascal M. Front Cardiovasc Med Cardiovascular Medicine INTRODUCTION: The rapid-deployment valve system (RDVS) was introduced to facility minimally invasive aortic valve replacement. In this study we evaluate the potential benefits of RDVS in elderly high-risk patients with endocarditis of the aortic valve. MATERIALS AND METHODS: Since the introduction of RDVS in our institution in December 2017 through October 2021, EDWARDS INTUITY rapid-deployment prosthesis (Model 8300A, Edwards Lifesciences, Irvine, CA, USA) has been implanted in a total of 115 patients for different indications by a single surgeon. Out of one-hundred and fifteen cases of RDVS implantation, seven patients with a median age of 77 yrs. (range 62–84yrs.), suffered from active infective endocarditis of the aortic valve. The median EuroSCORE II of these highly selected patient cohort was 77% (range 19–80%). Patient data were evaluated perioperatively including intra-operative data as well as in-hospital morbidity/mortality and follow-up after discharge from hospital. RESULTS: Three patients underwent previous cardiac surgery. Concomitant procedures were performed in six patients including, ascending aorta replacement (n = 3), mitral valve repair (n = 1), pulmonary valve replacement (n = 1), bypass surgery (n = 1), left atrial appendix resection (n = 1) and anterior mitral valve repair (n = 1). Median aortic cross-clamp and cardiopulmonary bypass time was 56 min (range 29–122 min) and 81 min (range 45–162 min.), respectively. Post-operative complications in these elderly high-risk patients were atrial fibrillation (n = 3) and re-exploration for pericardial effusion (n = 1). One pacemaker implantation was required on postoperative day 6 due to sick sinus syndrome. There was one in-hospital death (14%) and one during follow-up (14%). CONCLUSION: Rapid-deployment aortic valve system seems to be a viable option with acceptable morbidity and mortality in elderly high-risk patients with active infective endocarditis of the aortic valve. Frontiers Media S.A. 2022-03-22 /pmc/articles/PMC8980357/ /pubmed/35391848 http://dx.doi.org/10.3389/fcvm.2022.774189 Text en Copyright © 2022 Öner, Hemmer, Alozie, Löser and Dohmen. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cardiovascular Medicine
Öner, Alper
Hemmer, Christoph
Alozie, Anthony
Löser, Benjamin
Dohmen, Pascal M.
Introduction of the Rapid Deployment Aortic Valve System Use in Elderly Patients With Endocarditis
title Introduction of the Rapid Deployment Aortic Valve System Use in Elderly Patients With Endocarditis
title_full Introduction of the Rapid Deployment Aortic Valve System Use in Elderly Patients With Endocarditis
title_fullStr Introduction of the Rapid Deployment Aortic Valve System Use in Elderly Patients With Endocarditis
title_full_unstemmed Introduction of the Rapid Deployment Aortic Valve System Use in Elderly Patients With Endocarditis
title_short Introduction of the Rapid Deployment Aortic Valve System Use in Elderly Patients With Endocarditis
title_sort introduction of the rapid deployment aortic valve system use in elderly patients with endocarditis
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8980357/
https://www.ncbi.nlm.nih.gov/pubmed/35391848
http://dx.doi.org/10.3389/fcvm.2022.774189
work_keys_str_mv AT oneralper introductionoftherapiddeploymentaorticvalvesystemuseinelderlypatientswithendocarditis
AT hemmerchristoph introductionoftherapiddeploymentaorticvalvesystemuseinelderlypatientswithendocarditis
AT alozieanthony introductionoftherapiddeploymentaorticvalvesystemuseinelderlypatientswithendocarditis
AT loserbenjamin introductionoftherapiddeploymentaorticvalvesystemuseinelderlypatientswithendocarditis
AT dohmenpascalm introductionoftherapiddeploymentaorticvalvesystemuseinelderlypatientswithendocarditis